Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

China · Delayed Price · Currency is CNY

106.56

+17.76 (20.00%)

Jun 29, 2026, 3:04 PM CST

208.51% (1Y)

Market Cap	16.97B +238.8%
Revenue (ttm)	417.21M -0.4%
Net Income	-215.28M
EPS	-1.35
Shares Out	159.27M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,557,190
Open	91.00
Previous Close	88.80
Day's Range	88.00 - 106.56
52-Week Range	35.00 - 188.93
Beta	1.14
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About SHE:300436

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men’s health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2001

Employees 715

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300436

Full Company Profile

Financial Performance

In 2025, SHE:300436's revenue was 416.37 million, a decrease of -5.68% compared to the previous year's 441.46 million. Losses were -217.85 million, 39.4% more than in 2024.

Financial Statements